The Latest Obesity Drugs Present a Complex Financial and Legal Minefield for Employers Navigating Health Plan Costs
The advent of groundbreaking new medications designed to combat obesity, a class of drugs known as GLP-1 agonists, has ignited a familiar and often contentious debate for employers grappling with…
